A 2022 study published in the BMB Reports highlighted that while most cases of cervical cancer are due to HPV, around 3–8% ...

Young women in the South East have joined NHS bosses in urging people to take part in cervical cancer screening. Figures show ...

Cervical cancer, the fourth most common cancer among women, often develops silently, making early detection crucial. Symptoms ...

A woman from Berkshire is urging others to attend their cervical cancer screenings. Her message comes as NHS England South ...

Changes are set to come into force next month on how often some women in England are invited for cervical screening. Each ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

The survival benefit with cadonilimab in cervical cancer in the overall phase 3 COMPASSION-16 study population was sustained across prespecified subgroups.

Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

The DNA-based testing will be combined with the acetate acid (IVA) screening that is currently widely used across the nation ...

The NHS has explained the reason as to why cervical screenings are undergoing a huge change as millions of women in England ...